Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Intellipharmaceutics International Inc IPCIQ

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this... see more

Bullboard (GREY:IPCIQ)

View:
Comment by biggerron Mar 14, 2019 2:37pm

RE:it's a buy today for me

if and when FDA gives the PDUFA date for OxyER this stock will fly
Post by coolfooldumbguyon Feb 20, 2019 10:38am

it's a buy today for me

got in at .38 cents U.S. per share,we dumb Americans are big buyers today while you complacent Canadians watch us make money, i.e., you are spectators and we are participants,so glta.
Post by NOPAINNOGAIN123on Nov 20, 2018 8:37pm

20 % up after the news. Will see tomorrow?

Cash 18 millions . Now we are trading at 5 millions
Post by NOPAINNOGAIN123on Nov 20, 2018 8:34pm

Exclusive Distribution Agreements in Malaysia and Vietnam

https://www.intellipharmaceutics.com/news-media/press-releases/detail/184/intellipharmaceutics-reports-exclusive-distribution
Comment by NOPAINNOGAIN123on Oct 12, 2018 9:33am

RE:Ugh!

that is reason why it dropped. Maybe insider selling
Post by Ginro22on Oct 12, 2018 7:26am

Ugh!

https://ir.intellipharmaceutics.com/press-releases/detail/179/intellipharmaceutics-announces-pricing-of-13-million
Post by NOPAINNOGAIN123on Oct 11, 2018 12:35pm

Unbelievable

10/11/2018 1.48 1.92 1.21 1.25 255.1k -0.16 -11.35% 1.25 408.37k 1,080 10/10/2018 1.75 2 ...more  
Comment by whodathunkiton Oct 05, 2018 6:10pm

RE:Typical

And now we are down about 63% from the pre reverse split price on Sept 7th.......  Sad but predictable. Cheers.
Post by NOPAINNOGAIN123on Oct 05, 2018 4:04pm

30 % down on no news

Someone really want to get out
Post by whodathunkiton Sep 17, 2018 5:01pm

Typical

After the 10 to 1 reverse split, typical share price move.  Pumping the price up through a reverse split just allows the shorts to push the price that much further down.  What's it down ...more  
Comment by biggerron Aug 05, 2018 2:37pm

RE:IPCI On Watch Zone

how long the study is supposed to last, it started back in May
Post by Connorichon Jul 16, 2018 10:50pm

IPCI On Watch Zone

Keep a close eye on IPCI @ current levels. Here is the link to what to look at: https://bit.ly/2NWX9Gv
Post by archeo753on May 15, 2018 11:27am

Insider Buying

Filing Date  Transaction Date  Insider Name  Ownership Type  Securities  Nature of transaction  Volume or ...more  
Post by archeo753on Mar 20, 2018 4:59pm

Anson Funds Invests in IPCI

Short seller who helped put Nobilis (HLTH) through a world of hurt a couple of years ago (which it still hasn't recoverd from) has decided to go long on IPCI.  Could they have been behind ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities